ISCB vs. SCHA: Which Small-Cap ETF Should You Buy in 2026?

As of July 10, 2026, the Schwab U.S. Small-Cap ETF (SCHA) charges a lower 0.03% expense ratio versus 0.04% for iShares Morningstar Small-Cap (ISCB), but ISCB pays a higher dividend yield (1.3% vs 1.0%). Over the trailing 12 months, SCHA returned 34.7% vs ISCB’s 25.0%, with similar downside (5-year max drawdown: -30.8% vs -29.9%). The key differentiator is methodology/sector tilt—SCHA is more tech-heavy (22%) while ISCB is relatively more industrials-focused (18%)—so the “better buy” depends on whether investors want sector diversification versus yield.

Analysis

The real opportunity here is not the de minimis fee gap; it is the regime signal embedded in the sector mix. If small caps keep attracting capital, SCHA is the cleaner institutional vehicle because liquidity converts into tighter implementation costs and faster flow capture, while ISCB’s thinner book makes it more vulnerable to spread widening on any risk-off tape. That means the first-order winner in a sustained small-cap bid is likely the liquid proxy, not the higher-yield fund.

Second-order, the sector tilts matter more than the wrapper. SCHA is a more direct expression of lower real yields, duration relief, and multiple expansion in growthier small-cap software/semicap names, while ISCB is a slower-burn bet on domestic capex, infrastructure, and reshoring. If the market shifts from “rates down” to “earnings up,” the industrial basket should catch up; if not, the techier basket should keep outperforming because multiples react faster than end-demand.

Contrarian view: investors are probably overweighting yield and underweighting regime fragility. A 30-40 bps yield advantage is not enough to compensate for the wrong factor exposure if small-cap leadership rolls over, and the recent outperformance is vulnerable if real yields back up or credit spreads widen. The clean falsifier is a reversal in small-cap relative strength versus the S&P 500 or a failed rate-cut narrative over the next 4-8 weeks.

Key Decisions for Investors

• Long SCHA / short ISCB as a tactical 1-3 month relative-liquidity trade; thesis: if small-cap inflows persist, the larger, tighter vehicle should outperform on implementation friction alone. Stop if ISCB outperforms for two straight weeks on stronger industrial/capex prints.
• If you want industrial reindustrialization exposure, buy STRL outright rather than owning it diluted inside ISCB; 6-18 month upside is cleaner and more direct if infrastructure spend remains firm. Use pullbacks, not breakouts, as entry.
• For a rate-sensitive small-cap basket, prefer SCHA over ISCB and pair with a watchlist of higher-duration names like OKTA, LITE, and RVMD; this is the more levered expression if real yields keep falling over the next 1-3 months.
• Do not force a trade in the ETF issuer names; the economic impact from this comparison is on fund flows, not Morningstar operating fundamentals. Treat MORN as a no-trade unless there is evidence of meaningful ETF asset-gathering or index-licensing benefit.
• Set a risk alert on Russell 2000 relative performance and 10Y real yields: if small caps underperform the S&P 500 by >3% over 2-4 weeks or real yields rise, cut the SCHA relative long and reassess.